ask="17.20"
ask_size="300"
average_daily_volume="656474"
bid="15.60"
bid_size="100"
book_value="5.75"
change="+0.10"
change_from_200_day_moving_average="-1.40"
change_from_50_day_moving_average="0.64"
change_from_52_week_high="-11.24"
change_From_52_week_low="4.51"
change_in_percent="+0.60%"
close="16.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.25"
ebitda="-70.16M"
eps_estimate_current_year="-2.39"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.79"
ex_dividend_date="N/A"
float_shares="23963000"
high="16.85"
high_52_weeks="27.99"
last_trade_date="1/20/2017"
last_trade_price="16.75"
last_trade_size="13887"
last_trade_time="4:00pm"
low="16.50"
low_52_weeks="12.24"
market_capitalization="625.04M"
moving_average_200_day="18.15"
moving_average_50_day="16.11"
name="Global Blood Therapeutics
Inc."
notes="N/A"
one_year_target_price="50.83"
open="16.75"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-7.70%"
percent_change_from_50_day_moving_average="+3.99%"
percent_change_from_52_week_high="-40.16%"
percent_change_from_52_week_low="+36.85%"
previous_close="16.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.89"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37316000"
short_ratio="5.82"
stock_exchange="NMS"
symbol="GBT"
volume="269549"
weeks_range_52="12.24 - 27.99"
